N. V. Naryzhnaya

Pharmacology of mitochondrial permeability transition pore inhibitors

N. V. Naryzhnaya, Peter R. Oeltgen · Drug Development Research · 2019 · 40 citations

Mptp Inhibitors, Heart Failure, Mptp Opening +12

Hypertrophy and Insulin Resistance of Epicardial Adipose Tissue Adipocytes: Association with the Coronary Artery Disease Severity

N. V. Naryzhnaya, О. A. Koshelskaya, Olga Kharitonova et al. · Biomedicines · 2021 · 30 citations · Full text

High carbohydrate high fat diet causes arterial hypertension and histological changes in the aortic wall in aged rats: The involvement of connective tissue growth factors and fibronectin

N. V. Naryzhnaya, Yulia G. Birulina, Leonid Maslov et al. · Experimental Gerontology · 2021 · 27 citations

Obesity, Metabolic Syndrome, Hypertension +12

Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists

A Boshchenko, А. V. Mukhomedzyanov, А. S. Slidnevskaya et al. · International Journal of Molecular Sciences · 2024 · 26 citations · Full text

Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis

К. V. Zavadovsky, A. V. Vrublevsky, N. V. Naryzhnaya et al. · Current Cardiology Reviews · 2020 · 24 citations · Full text

Hypertension, Heart Failure, Pathology +17